Contributions of the Bone Microenvironment to Monoclonal Gammopathy of Undetermined Significance Pathogenesis | SpringerLink
Disease monitoring with quantitative serum IgA levels provides a more reliable response assessment in multiple myeloma patients | Leukemia
Monoclonal gammopathy of undetermined significance - Kyle - 2006 - British Journal of Haematology - Wiley Online Library
Monoclonal Gammopathies of Undetermined Significance and Smoldering Multiple Myeloma | Oncohema Key
Frontiers | Game of Bones: How Myeloma Manipulates Its Microenvironment
Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma - ScienceDirect
MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease | SpringerLink
Management of Monoclonal Gammopathy of Uncertain Significance | SpringerLink
Monoclonal Gammopathy of Undetermined Significance | IntechOpen
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS) | Blood Cancer Journal
Prevalence of Monoclonal Gammopathy of Undetermined Significance | NEJM
Monoclonal gammopathy of renal significance: Early diagnosis is key - ScienceDirect
Comparison of MGUS and multiple myeloma variants | Download Table
Polyclonal serum free light chain elevation is associated with increased risk of monoclonal gammopathies | Blood Cancer Journal
Myeloma Explained | Haematology | Oncology | onthewards
Cancers | Free Full-Text | Monoclonal Gammopathy of Undetermined Significance (MGUS)—Not So Asymptomatic after All
Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance | NEJM
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
IgM-MGUS and associated membranoproliferative glomerulonephritis during IVIG administration | SpringerLink
The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network | Haematologica
Cutaneous manifestations of monoclonal gammopathy | Blood Cancer Journal
Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study - The Lancet
Neuropathy associated with IgA monoclonal Gammopathy. A harbinger of AL amyloidosis - Journal of the Neurological Sciences
